’·è‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È •ªŽq–ò—Šw•ª–ì
publication
HOME
‹³Žöˆ¥ŽA
ƒƒ“ƒo[Ð‰î
Œ¤‹†ŠT—vEŒ¤‹†‚Ö‚Ì—U‚¢
Œ¤‹†‹ÆÑ
‹³ˆçŠˆ“®
Šw‰ïEŒ¤‹†‰ïEƒƒfƒBƒAŒfÚ
sŽ–
•åW
ƒAƒNƒZƒX
 
’·è‘åŠwd“_‰Û‘èu’ɂݍŽ•ž‚̍‘Û“IŒ¤‹†‹³ˆç‹’“_‚ÌŒ`¬v
 
 
 
Œ¤‹†‹ÆÑ
ƒz[ƒ€>Œ¤‹†‹ÆÑ>‰¢•¶Œ´’˜˜_•¶i‚Q‚O‚P4”Nj

‰¢•¶Œ´’˜˜_•¶@i‚Q‚O‚P4”Nj

1.      Omotuyi OI, Ueda H:Descriptor-based Fitting of LPA3 Antagonists into a Single Predictive Mathematical Model. Biomath 3i1406131j1-7,2014

2.      Jia N, Nakazawa Y, Guo C, Shimada M, Sethi M, Takahashi Y, Ueda H, Nagayama Y , Ogi T: A rapid, comprehensive system for assaying DNA repair activity and cytotoxic effects of DNA-damaging reagents. Nature Protocols 10 (1)12-24, 2014

3.      Uchida H, Nagai J, Ueda H :Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice. Mol Pain@10:71

4.      Omotuyi OI, Matsunaga H,Ueda H:Evidence for ProTƒ¿-TLR4/MD-2 binding: Molecular dynamics and gravimetric assay studies. Expert Opinion on Biological Therapy@Vol.15NO.S1,223-229

5.      Omotuyi OI,Ueda H: Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation. Computational Biology and Chemistry 55F14-22,2015

6.      Sumitani M,Ueda H,Hozumi J, Inoue R,Kogure T,Ogata T,Yamada Y: Minocycline Does Not Decrease Intensity of Neuropathic Pain, but Improves Its Affective Dimension. J Pain Palliat Care Pharmacother 1-6,2015

 
’·è‘åŠw
 
Copyright